Rapid system for surface hygiene monitoring

The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cleaning and protect their samples.

New automated solution for flexible molecular assays

The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.

Continuous sampling allows for instantaneous microbial detection

Biovigilant's IMD-A instruments employ an optical technology to continuously sample the air and immediately warn when microbial contamination is detected.

Higher performance UV-Vis spectrophotometry with double beams

The Biochrom Libra series of UV-Vis spectrophotometers now features double beams and variable bandwidths.

One-step cleaning system for use in clean rooms

The Micronswep cleaning system from Berendsen is a single action cleaning system developed for use in clean rooms.

Next generation sequencer in an accessible format

The GS Junior System is a new benchtop-sized next generation sequencing platform.

9 steps to perfect partnering

Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to perfect partnering.

High hopes for future partnering - the solution for struggling fairs

Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.

Academia - a strong player on the lab market

While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia increased ten percent last year, says Håkan Hjortsmark, sales manager at Perkin Elmer.

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Ozzy Osbournes DNA under lupp

Ett amerikanskt företag ska granska Ozzy Osbournes DNA för att ta reda på hur han kan ha överlevt 40 år av drog- och alkoholmissbruk.

Hallå där Peter Bramberg...

... som ansvarar för life science på Invest Sweden, vad är viktigast att den kommande regeringen genomför för life science-sektorn?

Iphone ersätter stetoskop

Tre miljoner läkare har en applikation som kan mäta patienters hjärtslag.

Protestprofessorer avstår kalas

Över hälften av de tolv professorer som kritiserat KI för centralstyre ska inte gå på 200-års festen. Två nekar på grund av missnöje mot ledningen medan två vill inte uppge anledning.

Phrmas nya vd

John Castellani blir ny vd för den amerikanska branschorganisationen för forskande läkemedelsföretag.

Nsgene får 43 miljoner

Danska Nsgene tecknar ett licensavtal som ger det amerikanska biotech-företaget Biogenidec rättigheter att marknadsföra Neublastin, trots att preparatet ännu inte är godkänt.

HPLC-system för stora biomolekyler

Agilent technologies lanserar två lite mindre varianter ur Infinity-serien, 1260 och 1220, tänkta att komplettera serien ur HPLC-perspektiv.

Dansk nedgång i klinisk utveckling

Hårdare krav på godkännanden i EU än i USA?

Ideon - Sweden's oldest science park

Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continue to invest in further development.

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performers have companies in phase III, according to Biotech Scandinavia's survey.

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Countries with a clear research goal are investing in new parks, and in China, the number

Trender i forskningsparkerna

Preklinisk forskning och låg omsättning är trender som dominerar i skandinaviens forskningsparker, enligt Biotech Scandinavias undersökning.